- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04845724
Dietary Phosphorus Load and Postprandial Serum Phosphate in HD Patients
The Effect of Dietary Phosphorus Load and Food Matrix on Postprandial Serum Phosphate in Hemodialysis Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Potential dietary strategies for controlling hyperphosphataemia include the use of protein sources with lower phosphorus bioavailability such as pulses and nuts, focus on phosphorus to protein ratios and the avoidance of all phosphate additives.
Method: Controlled crossover feeding study in 8 HD patients. On one day, participants were directly observed eating a standard low phosphorous diet and on the other day, a modified low phosphorus diet. The modified diet included beef and less dairy, with a lower phosphorus to protein ratio, as well as plant-based protein, whole grains, pulses and nuts containing phytates which reduces phosphorus bioavailability. Both diets were tailored for each participant to provide 1.1g protein/kg ideal body weight. Participants provided fasting bloods before breakfast, a pre-prandial sample before lunch and samples at one hour intervals for the four hours after the meal, for analysis of phosphate, potassium and intact parathyroid hormone (iPTH).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- > 18 years of age;
- on dialysis for > 3 months;
- pre-dialysis serum phosphate < 2.5 mmol/L and
- serum potassium < 6.3 mmol/L on most recent routine monthly blood test;
- urinary outputs of < 200 ml/day by self-report;
- being in their usual state of health
Exclusion Criteria:
- history of diabetes mellitus
- history of parathyroidectomy
- history of calciphylaxis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard Diet
The standard diet was based on the current dialysis diet sheet.
The standard diet main meal contained a higher proportion of foods with a higher phosphorus to protein ratio (salmon and dairy), and foods with higher phosphorus bioavailability (cake).
The diet was tailored for each participant to provide 1.1g protein/kg ideal body weight.
The major differences between the diets were at the main meal.
|
Other Names:
|
Experimental: Modified Diet
The modified diet, representative of the proposed modified phosphorus diet used food of lower phosphorus to protein ratio such as beef and less dairy.
Approximately 30% dietary phosphorus in the modified diet came from foods with significant phytate content such as pulses, nuts and whole grains.
The modified diet was tailored for each participant to provide 1.1g protein/kg ideal body weight.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Serum Phosphate
Time Frame: Post -prandial period (4 hours)
|
mmol/l
|
Post -prandial period (4 hours)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Serum Potassium
Time Frame: Post -prandial period (4 hours)
|
mmol/l
|
Post -prandial period (4 hours)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Serum intact Parathyroid Hormone
Time Frame: Post -prandial period (4 hours)
|
ng/L
|
Post -prandial period (4 hours)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Joseph Eustace, MB, University College Cork
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 16-CRFC-32
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemodialysis
-
National Taiwan University HospitalCompletedHemodialysis Complication | Hemodialysis-Induced SymptomTaiwan
-
Ain Shams UniversityCompleted
-
Imperial College Healthcare NHS TrustCompletedHemodialysisUnited Kingdom
-
Lawson Health Research InstituteUnknown
-
Tufts Medical CenterWithdrawn
-
Federico II UniversityUnknown
-
Hospital Clinic of BarcelonaSocietat Catalana de NefrologiaCompleted
-
Osaka UniversityCompleted
-
Chinese PLA General HospitalWithdrawn
Clinical Trials on Standard Diet
-
Eunice Kennedy Shriver National Institute of Child...CompletedType 1 Diabetes | Type 2 Diabetes | Impaired Glucose Metabolism
-
Ohio State UniversityRecruiting
-
Garvan Institute of Medical ResearchCompleted
-
Song LinUnknownGlioblastoma MultiformeChina
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruiting
-
Azienda Ospedaliero, Universitaria PisanaUnknown
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)Recruiting
-
University of Kansas Medical CenterTerminated
-
University of MinnesotaRecruitingSarcopenia | Dysbiosis | Colon CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNot yet recruiting